Clinical trials begin at Stony Brook to help treat COVID-19 patients
Posted: Apr 03, 2020 9:10 AM EDT
Officials at Stony Brook University Medicine says there a number of clinical trials that are being launched and designed to identify effective therapies for their critically ill patients.
Officials say the drug Remdesivir, developed to treat Ebola and Marburg, has been tested and appears to be effective in treating COVID-19 in China and in Washington state.
Led by Principal Investigator, Dr. Sharon Nachman, chief of the Division of Pediatric Infectious Diseases at Stony Brook Children's Hospital, Stony Brook Medicine has administered Remdesivir to two patients thus far with severe COVID-19.
http://longisland.news12.com/story/41970580/clinical-trials-begin-at-stony-brook-to-help-treat-covid19-patients